Results of induction therapy in adults with acute myeloid leukemia according to cytogenetic prognostic groups.
| . | Favorable . | Intermediate . | Unfavorable . | |||
|---|---|---|---|---|---|---|
| . | n . | CR . | n . | CR . | n . | CR . |
| Results of induction therapy from 3 cooperative groups. Identical standard induction therapy was used in all cytogenetic subtypes. A remarkable concordance among the 3 groups is demonstrated, although a rigorous comparison cannot be made due to minor differences among the studies in the classification of the cytogenetic prognostic groups. | ||||||
| Abbreviations: MRC, Medical Research Council; ECOG, Eastern Cooperative Oncology Group; SWOG, Southwestern Oncology Group; GOELAM, Groupe Ouest-Est Leukemies Aigues Myeloblastiques | ||||||
| MRC2(excluding children) | 289 | 90% | 853 | 84% | 130 | 57% |
| ECOG/SWOG27 | 121 | 84% | 278 | 76% | 184 | 55% |
| GOELAM24 | 48 | 87% | 226 | 76% | 36 | 58% |
| . | Favorable . | Intermediate . | Unfavorable . | |||
|---|---|---|---|---|---|---|
| . | n . | CR . | n . | CR . | n . | CR . |
| Results of induction therapy from 3 cooperative groups. Identical standard induction therapy was used in all cytogenetic subtypes. A remarkable concordance among the 3 groups is demonstrated, although a rigorous comparison cannot be made due to minor differences among the studies in the classification of the cytogenetic prognostic groups. | ||||||
| Abbreviations: MRC, Medical Research Council; ECOG, Eastern Cooperative Oncology Group; SWOG, Southwestern Oncology Group; GOELAM, Groupe Ouest-Est Leukemies Aigues Myeloblastiques | ||||||
| MRC2(excluding children) | 289 | 90% | 853 | 84% | 130 | 57% |
| ECOG/SWOG27 | 121 | 84% | 278 | 76% | 184 | 55% |
| GOELAM24 | 48 | 87% | 226 | 76% | 36 | 58% |